scholarly journals US IN LATIN AMERICA: KEY CURRENT INTERESTS AND METHODS OF THEIR ADVANCEMENT

Author(s):  
T. Kulinich

The present article reviews the current set of interests of the United States of America in respect of Latin American countries. The author believes that the key groups of interests pursued by the US in Latin America are as follows: political and security interests, economic interests, and combined interests, the most important of the latter being the interests relating to combating drug trafficking. The author believes that the economic interest, albeit being a secondary one in terms of formal hierarchy of interests, is in fact one of the core US interests in the region at present. The US is interested to preserve its influence upon the Latin American market, and further engage the Latin American workforce and industrial capacities to the benefit of the US economy. The US pursues its interests in Latin America, inter alia, through various integration projects, including NAFTA, CAFTA-DR, FTAA, and a range of free trade areas. The article also addresses the interest of the US in the field of prevention of drug trafficking, which constitutes an important area of cooperation between the US and the Latin American countries concerned. The author argues that, despite the fact that the current outcomes of the ongoing war on drugs may be perceived as controversial, the issue in question serves as a strong factor contributing to the growth of the US influence over, and its presence within, the region. The article also reviews key methods used by the US to further its interests in Latin America, including the classical methods and those relating to soft power.

2021 ◽  
pp. 186810262110282
Author(s):  
Xiaoyu Pu ◽  
Margaret Myers

This article examines how the Chinese elites are interpreting China’s growing presence in the Latin American and Caribbean (LAC) region and the various ways in which the United States is responding to China’s expanding activity in the region. Some of China’s elites caution that China’s international posturing could be overly assertive. Regarding China’s growing role in the LAC, they have made a note of US sensitivities, in addition to China’s challenges and limitations in various Latin American countries. Regarding the US response, some US concerns may be legitimate, and others are less valid. Looking ahead, even though US–China interactions in the LAC will remain competitive, the US and China could potentially avoid counterproductive policies while also pursuing pragmatic co-operation. While China does not yet face a serious problem of strategic overstretching in the LAC, China’s domestic debate on the topic will provide feedback to China’s policymakers and promote fruitful China–LAC relations.


1988 ◽  
Vol 30 (2-3) ◽  
pp. 77-86 ◽  
Author(s):  
Kenneth E. Sharpe

The US Policymakers Working on the 1988 Anti-Drug Abuse Act have clearly understood that going after the suppliers of narcotics is only part of the war on drugs; until US domestic demand is diminished, it will be difficult to bring this lucrative and illicit multinational business under control. There is, however, general agreement that something must be done about supply and that interdiction of drug shipments to the United States is only one means. The drug supply war's major focus is the growing, production, and shipment of narcotics within the Third World countries who are the suppliers, particularly in Latin America (Colombia, Mexico, Peru, and Bolivia head the list).Although there have been occasional attempts to “Americanize” anti-drug operations in Latin America (with the US government assuming drug enforcement functions as it did in Bolivia with Operation Blast Furnace in 1986), the major US option is to support the build-up of the Latin American governments' own drug-fighting capabilities by supplying funds, training, and equipment.


2021 ◽  
Vol 19 (5-6) ◽  
pp. 597-625
Author(s):  
Martha I. Chew Sánchez

Abstract This article addresses the impact of settler colonialism by the Spanish and United States in the American continent in forming the base, development, and power of capitalism in the West. It provides a general overview of the United States’ unequal economic relationships with Latin American countries since the end of the nineteenth century to the present. It highlights the role evangelist groups have in changing the way coup d’états have been taking place in the region, in particular, to countries that had democratically elected presidents who were part of the “Pink Tide” and had a program to counterbalance neoliberal policies that were contributing to unprecedented economic inequality in their societies. One of the central questions in this work is the role of coloniality within Latin American countries and between the US and Latin America in the coup d’état against Evo Morales in Bolivia on November 10, 2019.


2021 ◽  
Vol 61 (1) ◽  
Author(s):  
Gabriela Bittencourt Gonzalez Mosegui ◽  
Fernando Antõnanzas ◽  
Cid Manso de Mello Vianna ◽  
Paula Rojas

Abstract Background The objective of this paper is to analyze the prices of biological drugs in the treatment of Rheumatoid Arthritis (RA) in three Latin American countries (Brazil, Colombia and Mexico), as well as in Spain and the United States of America (US), from the point of market entry of biosimilars. Methods We analyzed products authorized for commercialization in the last 20 years, in Brazil, Colombia, and Mexico, comparing them to the United States of America (USA) and Spain. For this analysis, we sought the prices and registries of drugs marketed between 1999 and October 1, 2019, in the regulatory agencies’ databases. The pricing between countries was based on purchasing power parity (PPP). Results The US authorized the commercialization of 13 distinct biologicals and four biosimilars in the period. Spain and Brazil marketed 14 biopharmaceuticals for RA, ten original, four biosimilars. Colombia and Mexico have authorized three biosimilars in addition to the ten biological ones. For biological drug prices, the US is the most expensive country. Spain’s price behavior seems intermediate when compared to the three LA countries. Brazil has the highest LA prices, followed by Mexico and Colombia, which has the lowest prices. Spain has the lowest values in PPP, compared to LA countries, while the US has the highest prices. Conclusion The economic effort that LA countries make to access these medicines is much higher than the US and Spain. The use of the PPP ensured a better understanding of the actual access to these inputs in the countries analyzed.


2020 ◽  
pp. 1-3 ◽  
Author(s):  
Nubia Muñoz

It is too early to know which will be the final death toll from the Covid-19 or SARS-CoV-2 virus epidemy in Latin America since the epidemy is still active and we will not know when it will end. The curve for new infections and deaths has not reached yet a peak (Figure 1). In addition, we know little about the epidemiology of this new virus. The daily litany of the number of people infected with the number of admissions to hospitals and intensive care units and the number of deaths guides health authorities to plan health services and politicians to gauge the degree of confinement necessary to control the transmission of the virus, but it says little about the magnitude of the problem if we do not relate it to the population at risk. At the end of the pandemic, we will be able to estimate age-standardized death rates for the different countries, but until then the crude death rates will provide a first glance or snapshot of the death toll and impact of the pandemic from March to May 2020. These rates are well below those estimated in other countries in Europe and North America: Belgium (82.6), Spain (58.0), the United Kingdom (57.5), Italy (55.0), France (42.9), Sweden (41.4), and the US (30.7). (Johns Hopkins CSSE, May 30, 2020). However, in the European countries and the US the number of deaths has reached a peak, while this is not the case in Latin American countries. (Figure 1). It should be taken into account that the above rates are crude and therefore, some of the differences could be due to the fact that European countries have a larger proportion of the population over 70 years of age in whom higher mortality rates have been reported.


1977 ◽  
Vol 7 (2) ◽  
pp. 157-166 ◽  
Author(s):  
Milton Silverman

A survey was conducted on the promotion of 28 prescription drugs in the form of 40 different products marketed in the United States and Latin America by 23 multinational pharmaceutical companies. Striking differences were found in the manner in which the identical drug, marketed by the identical company or its foreign affiliate, was described to physicians in the United States and to physicians in Latin America. In the United States, the listed indications were usually few in number, while the contraindications, warnings, and potential adverse reactions were given in extensive detail. In Latin America, the listed indications were far more numerous, while the hazards were usually minimized, glossed over, or totally ignored. The differences were not simply between the United States on the one hand and all the Latin American countries on the other. There were substantial differences within Latin America, with the same global company telling one story in Mexico, another in Central America, a third in Ecuador and Colombia, and yet another in Brazil. The companies have sought to defend these practices by contending that they are not breaking any Latin American laws. In some countries, however, such promotion is in clear violation of the law. The corporate ethics and social responsibilities concerned here call for examination and action.


Author(s):  
Adriana L Iñiguez-Carrillo ◽  
Laura S Gaytán-Lugo ◽  
Rocío Maciel-Arellano ◽  
Miguel A García-Ruiz ◽  
Daniel Aréchiga

This paper describes and analyzes the state of research in Voice User Interfaces (VUIs) in Latin America based on the review of scientific documents published in SCOPUS from 1999 to June 2020, through a bibliometric analysis. We analyzed 419 academic papers. Although a gradual increase is observed over the years, the number of published documents has increased considerably since 2014. Brazil (44%) and Mexico (28%) are the countries with more documents published. Co-authorship occurs between Latin American countries (Brazil, Argentina, Mexico, Ecuador, and Costa Rica). However, the mayor collaboration from Latin American countries occurs with the United States, France, Germany, Spain, Portugal, the United Kingdom, and Japan. The main researched topics are studies of automatic speech recognition, artificial intelligence, speech processing, and human-computer interaction, which have grown over the past few years. Natural language processing, conversational agents, user experience, and chatbots are keywords related to more recent studies. Our analysis reveals that the primary active research developed in the short-term future are personal assistants and assistive technology using voice user interfaces.


1960 ◽  
Vol 2 (1) ◽  
pp. 77-82
Author(s):  
W. J. Kilgore

The development of philosophical ideas in Latin America has tended to reflect the major philosophical thought in Europe. There probably has been greater interest in philosophical ideas in Latin America than in the United States. In many instances, this interest has manifested itself not in the creative development of the content of philosophy but rather in the support which philosophical positions could provide proponents of the status quo or reformers with a basis for justification of social, political, educational, economic or religious programs.There has developed in many Latin American countries during this century an increasing number of works which are concerned with the theoretical aspect of philosophy.


1997 ◽  
Vol 39 (1) ◽  
pp. 71-83
Author(s):  
Shirley Christian

There has always been a certain attitude in Washington having to do with Latin America. It is that Latin America is not quite a grown-up place and, therefore, is worthy of intense US interest only when the region, or part of it, falls into a crisis that crosses paths with one of the US hot-button issues of the moment: drugs, immigration, human rights, communism (until recently) and, farther back, fascism. In other words, Latin America has been worthy of attention only when the United States decided to “do good” (e.g., human rights crusades), incorporate the region into efforts at solving US domestic problems (e.g., drugs), or needed firm support from the region in some international effort (e.g., the Cold War and World War II).


2006 ◽  
Vol 36 (142) ◽  
pp. 7-22
Author(s):  
"Mónica Bruckmann ◽  
Theotonio Dos Santos

At the beginning of the 20th century, social movements in Latin America were heavily influenced by anarchist immigrants from Europe and then by the ideological struggles around the Russian revolution. Beginning in the 1930s, many social movements started to incorporate into leftwing and populist parties and governments, such as the Cardenismo in Mexico. Facing the shift of many governments towards the left and the 'threat' of socialist Cuba, ultrarightwing groups and the military, supported by the US, responded in many countries with brutal repression and opened the neoliberal era. Today, after 30 years of repression and neoliberal hegemony, the social movements are gaining strength again in many Latin American countries. With the anti-globalization movement, new insurrections like the Zapatismo in Mexico, and some leftwing governments coming into power in Venezuela, Brasil and other countries, there appears to be a new turn in Latin America's road to the future.


Sign in / Sign up

Export Citation Format

Share Document